Yasutomo Nasu's Biography

Yasutomo Nasu, Professor, Okayama University

Yasutomo Nasu, M.D., Ph.D. (TOMO) is a professor and chairman of Urology and also Executive Director for Research at Okayama University. He serves as a board director member of Japanese Society of Gene Therapy (JSGT, President 2017), Japanese Society of Endourology(JSE, President elect 2020). His major research interest is a promotion of translational research (TR) in the field of urology such as gene therapy and cell therapy. His research carrier on TR started as a fellow of Baylor College of Medicine with Peter T. Scardino and has many international research projects. He is a principal or co-principal investigator of multiple gene therapy trials and international grant projects. His clinical interests are uro-oncology, minimally invasive treatments including brachytherapy and robotic surgery.

Prostate Cancer Gene Therapy as Translational Research

Tuesday, 12 November 2019 at 11:10

Add to Calendar ▼2019-11-12 11:10:002019-11-12 12:10:00Europe/LondonProstate Cancer Gene Therapy as Translational ResearchCell and Gene Therapy Asia 2019 in Kobe, JapanKobe, JapanSELECTBIOenquiries@selectbiosciences.com

Prostate is an ideal target organ for the gene therapy as a translational research (TR). It has advantages as follows : prostate is not a life keeping organ, can be approached easily by ultrasound as a routine clinical technique and PSA is a potent tumor marked for the evaluation of clinical response. Many clinical gene therapy trials for prostate cancer have been conducted in many institutes showing clinical safety and efficacy including Japanese trial. Intraprostatic therapeutic gene transduction (in situ gene therapy) is one of the potent therapeutic option for prostate cancer gene therapy aiming at anti-metastatic benefits through the generation of immune cell-mediated cytotoxic activities that affect not only the primary tumor but also metastatic lesion. In this lecture, role of academia for the development of gene therapy as a translational research will be discussed base on our experience for 20 years. I would like to discuss about the present problem and future direction for the development of gene therapy.

Add to Calendar ▼2019-11-11 00:00:002019-11-12 00:00:00Europe/LondonCell and Gene Therapy Asia 2019Cell and Gene Therapy Asia 2019 in Kobe, JapanKobe, JapanSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors

	Lab-on-a-Chip, Microfluidics, & Organ-on-a-Chip Asia 2024 Location: Tokyo, Japan Date: 07/11/2024 - 08/11/2024

	Organoids and Spheroids Europe 2024 Location: Rotterdam, The Netherlands Date: 24/06/2024 - 25/06/2024

	Lab-on-a-Chip and Microfluidics World Congress 2024 Location: Laguna Hills, California Date: 18/11/2024 - 20/11/2024